E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes

Figure 6

Kaplan–Meier analysis of GC patients with different expression levels of E2F1 and stemness-associated genes. All patients were divided into three groups according to the expression level of (a) E2F1 and Nanog, (b) E2F1 and OCT4, (c) E2F1 and BMI1, and (d) E2F1 and CD44. The high group referred to patients with high expression of both E2F1 and stemness-associated gene; the low group referred to patients with low expression of both E2F1 and stemness-associated gene; the middle group referred to the remaining patients. OS differences among the three groups were compared using Kaplan–Meier analysis.

(a)

(b)

(c)

(d)